GRIN2B and pancreatic neoplasm: NMDA receptors are important regulators of pancreatic cancers and pharmacological blockade of NMDA receptors, especially the GluN2B sub-unit, was found to have significant growth inhibitory effects on human pancreatic tumor cells in the orthotopic xenograft mice model (North et al., 2017).